GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.
Although interstitial lung disease typically develops early in systemic sclerosis, a study of 969 patients revealed that ILD presenting after 7 years of disease showed identical progression rates and severity patterns as early-onset cases, challenging traditional monitoring assumptions.
A recent study found that nearly half of systemic sclerosis patients with late-onset interstitial lung disease experience disease progression within four years. Key risk factors for late-onset ILD were identified, and surveillance is recommended, although optimal monitoring methods have yet to be established.
While biological therapies for RA show similar efficacy rates (~60% ACR20, ~40% ACR50, ~20% ACR70), researchers highlight safety profiles as a critical factor in guiding rheumatoid arthritis treatment selection.
A recent study published in JAMA Network Open reveals gender differences in electronic health record (EHR) usage among surgeons, with female surgeons writing significantly longer progress notes than their male counterparts.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.